/Dr. Genevieve Boland
Multi-modality approach to predicting and monitoring immunotherapy response and resistance
Multi-modality approach to predicting and monitoring immunotherapy response and resistance
26 May 2021

Watch this keynote presentation by, Dr. Genevieve Boland, Assistant Professor, Harvard Medical School, titled: Multi-modality approach to predicting and monitoring immunotherapy response and resistance. This talk was presented at the SelectScience® Virtual Cancer and Immunology Research Summit 2021.

Related Scientists

Related Content